Boston Scientific Corp (BSX) Stock Price, Quote & News

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal sur...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 683 4000

Website: www.bostonscientific.com

Address:

300 Boston Scientific Way, Marlborough, United States

Game_Day Feb. 3 at 10:10 PM

FEB 4 TOP 3 Potential reach Bullish $TTWO 225+ $CRML 15.68+ $BSX 92.24+

0 · Reply

Steward59 Feb. 3 at 8:42 PM

$BSX why the fucking sentiment became bearish from bullish

1 · Reply

DonCorleone77 Feb. 3 at 7:35 PM

$LLY $ABBV $UBER $BSX $JCI Some notable companies reporting before tomorrow's open, with earnings consensus estimates: - Eli Lilly (LLY), consensus $6.93 - Abbvie (ABBV), consensus $2.65 - Uber (UBER), consensus 78c - Boston Scientific (BSX), consensus 78c - Johnson Controls (JCI), consensus 84c - Yum Brands (YUM), consensus $1.76 - GE Healthcare (GEHC), consensus $1.40 - Cognizant (CTSH), consensus $1.32 - Foxa (FOXA), consensus 52c - Equifax (EFX), consensus $2.05 - Fortive (FTV), consensus 84c

0 · Reply

eWhispers Feb. 3 at 6:35 PM

#earnings before the open on Wednesday, February 4, 2026 https://www.earningswhispers.com/calendar $UBER $LLY $NVO $ABBV $BSX

0 · Reply

Stonkapedia Feb. 3 at 4:15 PM

$BSX drive it into the dirt before ER. 😂

0 · Reply

Stonkapedia Feb. 3 at 2:39 PM

$BSX

0 · Reply

ZacksResearch Feb. 3 at 2:03 PM

Are MedTech stocks bracing for a bumpy Q4 ride? 🚑 The sector's earnings are expected to decline 2.4% despite 8.7% revenue growth, with major players like $BSX and $ALGN set to report results tomorrow. AI-driven innovations are expected to support performance, but geopolitical tensions and supply-chain disruptions could weigh heavily. Find out what's in store for these stocks tomorrow 👉 https://www.zacks.com/stock/news/2827637/medtech-stocks-to-watch-for-earnings-on-feb-4-bsx-algn-more?cid=sm-stocktwits-2-2827637-body-31611&ADID=SYND_STOCKTWITS_TWEET_2_2827637_BODY_31611

0 · Reply

erevnon Feb. 3 at 1:46 PM

Barclays maintains Boston Scientific $BSX at Overweight and lowers the price target from $136 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

ZacksResearch Feb. 3 at 1:03 PM

Q4 earnings season is heating up — but the setup is tricky ⚠️📊 $BSX, $ALGN, $STE, and $TECH are set to report as sector profits slow, even while revenue growth stays steady — a classic margin-vs-growth tension to watch closely. See what this earnings setup could mean for these names 👉 https://www.zacks.com/stock/news/2827637/medtech-stocks-to-watch-for-earnings-on-feb-4-bsx-algn-more?cid=sm-stocktwits-2-2827637-teaser-31608&ADID=SYND_STOCKTWITS_TWEET_2_2827637_TEASER_31608

0 · Reply

Stonkapedia Feb. 2 at 6:46 PM

$BSX crush earnings. Get outta this rut. Thanks.

0 · Reply

Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Feb 2, 2026, 5:02 PM EST - 1 day ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)

Jan 29, 2026, 9:39 AM EST - 5 days ago

Artisan Global Opportunities Fund Q4 2025 Portfolio Update

ARGX BKR COF COIN INSM LEG LHX

Jan 26, 2026, 2:54 PM EST - 8 days ago

Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage

APP CMI MNST WYNN

Jan 22, 2026, 12:05 AM EST - 13 days ago

Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity

ADBE AMZN AON MELI SAP SPOT

Jan 16, 2026, 10:00 AM EST - 18 days ago

How Low Can Boston Scientific Stock Go When Markets Turn Sour?

Jan 15, 2026, 12:05 PM EST - 19 days ago

Boston Scientific Corporation (BSX) M&A Call Transcript

Jan 15, 2026, 11:03 AM EST - 19 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

Jan 15, 2026, 9:11 AM EST - 19 days ago

Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach

PEN

Jan 15, 2026, 8:45 AM EST - 19 days ago

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.

PEN

Jan 15, 2026, 8:11 AM EST - 19 days ago

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments

PEN

Jan 15, 2026, 7:19 AM EST - 19 days ago

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

PEN

Jan 15, 2026, 7:07 AM EST - 19 days ago

Boston Scientific to buy Penumbra in deal valued at $14.5 billion

PEN

Jan 15, 2026, 7:00 AM EST - 19 days ago

Boston Scientific announces agreement to acquire Penumbra, Inc.

PEN

Jan 13, 2026, 3:55 PM EST - 21 days ago

Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 7:00 AM EST - 22 days ago

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

Jan 2, 2026, 8:00 AM EST - 4 weeks ago

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Dec 28, 2025, 2:40 AM EST - 5 weeks ago

Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside

Dec 2, 2025, 4:23 PM EST - 2 months ago

Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript

Nov 18, 2025, 11:48 AM EST - 2 months ago

Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

Nov 6, 2025, 8:10 AM EST - 3 months ago

Artisan Global Opportunities Fund Q3 2025 Portfolio Update

AMZN DKS INSM LHX SPOT TEAM VRTX

Nov 3, 2025, 8:00 AM EST - 3 months ago

Boston Scientific announces upcoming investor conference schedule

Oct 27, 2025, 1:27 PM EDT - 3 months ago

Baron Health Care Fund Q3 2025 Top Contributors And Detractors

ARGX INSM ISRG LLY RDNT

Oct 23, 2025, 11:34 PM EDT - 3 months ago

Boston Scientific Q3: Operational Improvements Warrant An Upgrade To A Buy

Oct 23, 2025, 9:41 AM EDT - 3 months ago

These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings

Oct 22, 2025, 2:53 PM EDT - 3 months ago

Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript

Oct 22, 2025, 7:36 AM EDT - 3 months ago

Boston Scientific lifts annual profit forecast on strong demand for heart devices

Oct 22, 2025, 6:59 AM EDT - 3 months ago

Boston Scientific Raises Outlook on Continued Cardiovascular Growth

Oct 22, 2025, 6:30 AM EDT - 3 months ago

Boston Scientific announces results for third quarter 2025

Oct 21, 2025, 11:07 AM EDT - 3 months ago

It's time to scoop up undervalued stocks in this critical sector of the economy

ISRG SYK BDX BDYN BIO FEGE JGLO

Oct 17, 2025, 7:09 AM EDT - 3 months ago

Boston Scientific buys Nalu Medical for $533 million

Oct 17, 2025, 7:00 AM EDT - 3 months ago

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

Oct 13, 2025, 2:53 PM EDT - 4 months ago

9 Stocks to Buy Before Their Earnings Reports

ADBE CSCO GM OKTA ZM

Oct 9, 2025, 5:00 AM EDT - 4 months ago

4 Top AI-Powered Healthcare Stocks

OPRX VEEV ZEPP

Sep 30, 2025, 6:12 PM EDT - 4 months ago

Boston Scientific Corporation (BSX) Analyst/Investor Day Transcript

Sep 19, 2025, 7:01 AM EDT - 4 months ago

Top 3 Health Care Stocks That May Explode In September

ATYR RVPH

Sep 2, 2025, 8:00 AM EDT - 5 months ago

Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results

Aug 25, 2025, 2:26 PM EDT - 5 months ago

8 Growth Stocks to Buy That Aren't Technology. What Makes Them Worth It.

COF UBER

Aug 9, 2025, 8:53 AM EDT - 6 months ago

Boston Scientific Corporation Is Expensive But Worth It

Aug 7, 2025, 9:45 PM EDT - 6 months ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX EW EXAS GH ISRG LLY MASI

Aug 6, 2025, 8:07 AM EDT - 6 months ago

Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions

Jul 31, 2025, 9:52 AM EDT - 6 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

CAH DXCM EW ISRG LLY PODD SYK

Jul 23, 2025, 12:10 PM EDT - 6 months ago

Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript

Jul 23, 2025, 10:46 AM EDT - 6 months ago

Cramer's Stop Trading: Boston Scientific

Jul 23, 2025, 7:58 AM EDT - 6 months ago

Boston Scientific lifts annual profit view on steady heart devices demand

Jul 23, 2025, 6:30 AM EDT - 7 months ago

Boston Scientific announces results for second quarter 2025

Jul 22, 2025, 11:00 AM EDT - 7 months ago

How To Trade Boston Scientific Stock Ahead Of Its Upcoming Earnings?

Jul 11, 2025, 5:05 AM EDT - 7 months ago

North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf

Jul 7, 2025, 7:00 AM EDT - 7 months ago

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

Game_Day Feb. 3 at 10:10 PM

FEB 4 TOP 3 Potential reach Bullish $TTWO 225+ $CRML 15.68+ $BSX 92.24+

0 · Reply

Steward59 Feb. 3 at 8:42 PM

$BSX why the fucking sentiment became bearish from bullish

1 · Reply

DonCorleone77 Feb. 3 at 7:35 PM

0 · Reply

eWhispers Feb. 3 at 6:35 PM

#earnings before the open on Wednesday, February 4, 2026 https://www.earningswhispers.com/calendar $UBER $LLY $NVO $ABBV $BSX

0 · Reply

Stonkapedia Feb. 3 at 4:15 PM

$BSX drive it into the dirt before ER. 😂

0 · Reply

Stonkapedia Feb. 3 at 2:39 PM

$BSX

0 · Reply

ZacksResearch Feb. 3 at 2:03 PM

0 · Reply

erevnon Feb. 3 at 1:46 PM

Barclays maintains Boston Scientific $BSX at Overweight and lowers the price target from $136 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

ZacksResearch Feb. 3 at 1:03 PM

0 · Reply

Stonkapedia Feb. 2 at 6:46 PM

$BSX crush earnings. Get outta this rut. Thanks.

0 · Reply

DiamondCapital Feb. 2 at 3:06 PM

$CSDX Put this on your watchlist asap Their CS Protect-Hydrogel currently under FDA review Competitors: SpaceOAR™ Hydrogel System which was acquired by $BSX Boston Scientific for $500M Barrigel® acquired by Telefex $TFX for $600M And literally no other direct competitors in market Another similar one but not a (hydrogel spacer) is BioProtect Balloon Implant™ System currently in the process of being acquired for $200M as of Jan,26, 2026 This is a pretty big OTC play. High value/low competition niche(hydrogel spacers), which seen major buyouts in the past. In the range of $500M-$600M Going to share more DD on this play..

1 · Reply

Steward59 Jan. 30 at 7:29 PM

$BSX believe in science and invest health care

0 · Reply

Steward59 Jan. 30 at 7:28 PM

$BSX 🚀❤️

0 · Reply

Steward59 Jan. 30 at 7:27 PM

$BSX

0 · Reply

OffHisGame88 Jan. 30 at 6:46 PM

$BSX Bullish - outperforming heavily on a bad day

0 · Reply

jim22u Jan. 29 at 10:30 PM

$BSX Might get a positive bump tomorrow from SYK's solid report.

0 · Reply

redocean24 Jan. 29 at 1:34 PM

$BSX LONG. One of the most steady on the market. In the very least will be over $100 in 30 days or less.

0 · Reply

Steward59 Jan. 29 at 8:28 AM

$BSX is everything ok with this company when 100+ is coming???

0 · Reply

redocean24 Jan. 29 at 3:19 AM

$UMAC and $BSX are the only “stocks” I own as of now. Both behaving nicely…

0 · Reply

ZacksResearch Jan. 28 at 12:37 PM

$BSX earnings preview: Will Q4 continue the solid performance? 📊 Boston Scientific is poised for another solid quarter with the Zacks Consensus Estimate pegging revenue at $5.27B (+15.4% YoY) and EPS at 78 cents (+11.4% YoY). The MedSurg and Cardiovascular divisions are expected to drive growth, bolstered by innovative products like the Axios platform and AGENT Drug-Coated Balloon. Discover the full Q4 setup here 👉 https://www.zacks.com/stock/news/2824028/will-robust-medsurg-performance-fuel-boston-scientifics-q4-earnings?cid=sm-stocktwits-2-2824028-body-30586&ADID=SYND_STOCKTWITS_TWEET_2_2824028_BODY_30586

0 · Reply

ZacksResearch Jan. 28 at 11:37 AM

$BSX Q4 earnings setup looks interesting — is MedSurg the real driver here? 🚀 Boston Scientific heads into Q4 with strong MedSurg momentum alongside Cardiovascular growth, as revenue and EPS estimates point to double-digit gains. Does this strength translate into upside for the stock? Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2824028/will-robust-medsurg-performance-fuel-boston-scientifics-q4-earnings?cid=sm-stocktwits-2-2824028-teaser-30585&ADID=SYND_STOCKTWITS_TWEET_2_2824028_TEASER_30585

0 · Reply

Steward59 Jan. 26 at 5:58 PM

$BSX

0 · Reply

Market Cap	138.65B
Revenue (ttm)	16.75B
Net Income (ttm)	1.85B
EPS (ttm)	N/A
PE Ratio	31.30
Forward PE	26.80
Profit Margin	11.07%
Debt to Equity Ratio	0.49

Volume	20,357,300
Avg Vol	10,851,672
Day's Range	N/A - N/A
Shares Out	1.48B
Stochastic %K	20%
Beta	0.67
Analysts	Strong Sell
Price Target	$125.53